ODDB.org: Open Drug Database

Novo Nordisk Pharma AG - Concizumab HAwI 300 mg/3.0 mL (100 mg/mL), Injektionslösung im Fertigpen

Swissmedic Registration	69076	Sequence	04
Product name	Concizumab HAwI 300 mg/3.0 mL (100 mg/mL)	Description	Injektionslösung im Fertigpen
ATC-Classification	B02BX	ATC-Description	Other Systemic Hemostatics
Introduction of Sequence	22.08.2023

Composition

concizumabum 100 mg, histidinum, arginini hydrochloridum, natrii chloridum, saccharum, polysorbatum 80, phenolum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1.0 ml corresp. natrium max. 0.0362 mmol.

Packungsbestandteile

Galenic Form

Injektionslösung im Fertigpen

Excipiens

Active Agent	Dose
Concizumabum	100mg / 1ml

Inactive agents
Acidum Hydrochloridum ad Ph
Arginine Hydrochloride
Histidine
Sodium Chloride
Natrii Hydroxidum ad Ph
Phenol
Polysorbatum 80
Saccharum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
No entries have been found.

2025	©ywesee GmbH